New York City, NY -- (SBWIRE) -- 01/08/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Intel Corporation (NASDAQ:INTC), General Electric Company (NYSE:GE), Generex Biotechnology Corporation (OTCMKTS:GNBT), Pfizer Inc. (NYSE:PFE)
Intel Corporation (NASDAQ:INTC) declined -0.63% recently, while trading on 5.60 million shares at the price of $25.42 If we look at its trading history of the past 52 weeks, the share price suffered a low of $20.10 and was moved to its maximum level of $26.04.The stock changed hands in a range of $25.41 to $25.71, bringing its market capitalization at about $126.72 billion. Intel Corporation designs and manufactures integrated digital technology platforms. A platform consists of a microprocessor and chipset. The Company’s platforms are used in a range of applications, such as personal computers (PCs) (including Ultrabook systems), data centers, tablets, smartphones, automobiles, automated factory systems and medical devices.
Is it the Right to Grab INTC after the Recent Slump? Get Free Trend Analysis Here
General Electric Company (NYSE:GE) added 0.17% recently, in the current trading session, at $27.29 with a total volume of 5.69 million shares. The stock, on average, trades on a volume of 33.36 million shares. In the past 52 weeks, the share price has not declined below $20.68 and above $28.09.It floated in a range of $27.17 to $27.36 during the recent trading session, with a beta value of 1.81.Its market capitalization now moved to about $276.05 billion. General Electric Company (GE) is a diversified technology and financial services company. The products and services of the Company range from aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing and industrial products.
Why Should Investors Buy GE After The Recent Gain? Just Go Here and Find Out
Generex Biotechnology Corporation (OTCMKTS:GNBT) recently recorded a fall of -7.07% and was moving within a range of $0.04-$0.04. Its current trading price is $0.0381. The share price hit its 52-week low of $3.63 and $2.67 was the best price. The stock completed the day with a total volume of 3.63 million shares, versus an average volume of 2.67 million shares. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Will GNBT Reach the Bottom after Yesterday’s Correction? Find Out Here
Pfizer Inc. (NYSE:PFE) added 0.59% in its current trading activity, bringing its market capitalization around $200.27 billion. The total number of shares that changed hands during the current session up till now was 3.66 million shares, as compared to average trading volume of 23.66 million shares. The share price after opening at $30.78 made a high of $30.95 and hovered above $30.65, while its recent trading price was $30.93. Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare.
What was the Moving Force behind PFE on Bullish Run? Read This Research Report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)